Vicore Pharma Holding AB
VICO.ST · Health Technology · Biotechnology · SE
26 employees · vicorepharma.com
About
Vicore Pharma Holding AB, headquartered in Stockholm, Sweden, is a biotechnology company focused on developing drugs for interstitial lung diseases and related conditions. The company, listed on the stock market since December 10, 2015, employs 26 full-time staff and operates within the Health Care sector. Its portfolio includes small molecules targeting anti-inflammation, nerve regeneration, and cardiovascular diseases, with a wholly owned subsidiary structure under Mintage Scientific AB.
Annual results
Reported figures, SEK
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2024 | 109M | -168M | -154.1% | — |
| 2023 | — | -310M | — | — |
| 2022 | — | -288M | — | — |
| 2021 | — | -296M | — | — |
| 2020 | — | -146M | — | — |
VICO.ST in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Vicore Pharma Holding AB are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.